| Patents for C12N 9 - Enzymes, e.g. ligases (6.); Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating, or purifying enzymes (141,535) |
|---|
| 01/22/2004 | WO2004006990A2 Medical device and method for tissue removal and repair |
| 01/22/2004 | WO2004006962A2 A tissue factor binding immunoconjugate comprising factor viia |
| 01/22/2004 | WO2004006949A1 Methods and compositions for regulation of mammalian hair growth |
| 01/22/2004 | WO2004006939A1 Blocking inflammation by inhibiting st3-gal-vi activity |
| 01/22/2004 | WO2004006838A2 Novel kinases |
| 01/22/2004 | WO2004006658A1 Method of constructing caffeineless coffee plant by genetic recombination |
| 01/22/2004 | WO2003102143A3 HUMAN COACTIVATOR-ASSOCIATED ARGININE METHYLTRANSFERASE 1 (hCARM1) |
| 01/22/2004 | WO2003089457A3 Peptide inhibitors of protein kinase c ϝ for pain management |
| 01/22/2004 | WO2003087369A3 Ribozyme capable of specifically cleaving mmp-13 |
| 01/22/2004 | WO2003078577A9 Cloning of cytochrome p450 genes from nicotiana |
| 01/22/2004 | WO2003076561A3 Recombinase fusion protein with enhanced cellular uptake |
| 01/22/2004 | WO2003072800A3 Haemophilus adherence and penetration proteins |
| 01/22/2004 | WO2003067213A3 Modulation of sulfate permease for photosynthetic hydrogen production |
| 01/22/2004 | WO2003066087A3 Kinases involved in the regulation of energy homeostasis |
| 01/22/2004 | WO2003048316A3 Polynucleotides encoding novel human mitochondrial and microsomal glycerol-3-phosphate acyl-transferases and variants thereof |
| 01/22/2004 | WO2003048303A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/22/2004 | WO2003042371A3 55053, a novel human eukaryotic kinase and uses therefor |
| 01/22/2004 | WO2003038115A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/22/2004 | WO2003038105A3 Sequences for the preparation of 5-ketogluconic acid from gluconic acid |
| 01/22/2004 | WO2003020962A3 Method of identifying glycosyl transferase binding compounds |
| 01/22/2004 | WO2003016839A3 Modified railroad worm red luciferase coding sequences |
| 01/22/2004 | WO2003013234A3 Method for the in vivo screening of the biological activity of an acetylcholinesterase inhibitor compound on one or more cellular targets other than acetylcholinesterase |
| 01/22/2004 | WO2002092622A8 Dipeptide derivatives having a n-terminal 2-thioacyl group as vasopeptidase inhibitors |
| 01/22/2004 | WO2002079452A3 Isolated human phosphatase proteins, nucleic acid molecules encoding human phosphatase proteins, and uses thereof |
| 01/22/2004 | WO2002079451A3 Isolated human enzyme proteins, nucleic acid molecules encoding human enzyme proteins, and uses thereof |
| 01/22/2004 | WO2002069886A3 Modified proteins, designer toxins, and methods of making thereof |
| 01/22/2004 | US20040016021 Recombinant viral expression constructs of human alpha galactosidase nucleotide sequences |
| 01/22/2004 | US20040016008 Rodent whose genome comprises a mutant amyloid precursor protein transgene and an acetylcholinesterase transgene; use in identifying agents that affect the progression of Alzheimer's disease |
| 01/22/2004 | US20040016005 Large-scale production of recombinant butyrylcholinesterase in cell culture, and in milk and/or urine of transgenic mammals; can be used to treat and/or prevent organophosphate pesticide poisoning, nerve gas poisoning, cocaine intoxication |
| 01/22/2004 | US20040014958 tRNA synthetases, metRS |
| 01/22/2004 | US20040014942 Transformation cells by introduction of a false-sense mutation at a target codon of a gene coding for a protein necessary for the growth of the cells, such protein synthesized from the gene thus mutated is non functional |
| 01/22/2004 | US20040014939 Comprises peptide with degratory activity for diagnosis, prevention and treatment of defects in vasodilation, hypotension and hypoglycemia |
| 01/22/2004 | US20040014876 Deproteinizing agent, deproteinized natural rubber latex using the same, and method of producing rubber product |
| 01/22/2004 | US20040014702 Mammalian prostaglandin H synthase-2 |
| 01/22/2004 | US20040014666 Isolated human enzyme, nucleic acid molecules encoding human enzyme, and uses thereof |
| 01/22/2004 | US20040014659 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/22/2004 | US20040014647 Apicidin-derivatives, their synthetic methods and anti-tumor compositions containing them |
| 01/22/2004 | US20040014635 Anticancer agents |
| 01/22/2004 | US20040014197 Microbial strains and process for the manufacture of biomaterials |
| 01/22/2004 | US20040014195 Nitrilases have increased activity and stability at increased pH and temperature |
| 01/22/2004 | US20040014194 Beta-secretase crystals and methods for preparing and using the same |
| 01/22/2004 | US20040014193 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/22/2004 | US20040014192 PR/SET-domain containing nucleic acids, polypeptides, antibodies and methods of use |
| 01/22/2004 | US20040014191 Comprises nucleotide sequences and viral vector coding nitroreductase for generating cytotoxic 4- hydroxylamine to treat cancer; site diredted mutagenesis; prodrugs; anticarcinogenic agents |
| 01/22/2004 | US20040014190 Stable plasminogen activator inhibitor for treatment of thrombosis and cardiovascular diseases |
| 01/22/2004 | US20040014187 Comprises genetically engineered protease for treatment tumors; gene therapy |
| 01/22/2004 | US20040014182 Nucleotide sequence encoding a benzaldehyde lyase, and process for stereoselectively synthesizing 2-hydroxyketones |
| 01/22/2004 | US20040014180 Method for the microbial production of metabolic products, polynucleotides from coryneform bacteria and use thereof |
| 01/22/2004 | US20040014175 Producting proteases which differ from wild type in at least one amino acid for use in industrial and food applications such as textile treatment, detergents and protein degradation |
| 01/22/2004 | US20040014170 Controlling formation of acidic sugar chain associated with heterologously expressed glycoproteins in pichia; preparing less antigenic polypeptides; pharmacology; drug design |
| 01/22/2004 | US20040014167 Process for producing biopterin |
| 01/22/2004 | US20040014164 Dried composition comprised of glassy matrix for improving stability and storage of proteins |
| 01/22/2004 | US20040014163 Immunoassay mixture for measuring calcium-dependent glutamate dehydrogenase activities and treating bone, teeth and oral diseases |
| 01/22/2004 | US20040014162 Regulating levels of tyrosine phosphatase activity of protein tyrosine phosphatase zeta/receptor-like protein (RPTP beta/zeta) in cells and/or tissues; antitumor agents; angiogensis inhibitors |
| 01/22/2004 | US20040014158 Protein conjugates, methods, vectors, proteins and DNA for producing them, their use, and medicaments and vaccines containing a certain quantity of said protein conjugates |
| 01/22/2004 | US20040014147 Utilizing an adenosine kinase as a surrogate analyte; methods of using the compounds in a variety of in vitro, in vitro and ex vivo contexts |
| 01/22/2004 | US20040014130 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/22/2004 | US20040014126 Comprises peptide with pyruvate dehydrogenase activity for monitoring enzyme modulators; high-throughput assay; drug screening; enzyme inhibitors; tumor diagnosis; antitumor agents |
| 01/22/2004 | US20040014121 Methionyl tRNA synthetase (metS) polypeptides and DNA (RNA) encoding them and methods for producing such polypeptides by recombinant techniques; utilizing metS polypeptides to screen for antibacterial compounds |
| 01/22/2004 | US20040014116 Plant caffeic acid 3-0-methyltransferase homologs |
| 01/22/2004 | US20040014112 Novel human kinase proteins and polynucleotides encoding the same |
| 01/22/2004 | US20040014099 Susceptibility gene for human stroke; methods of treatment |
| 01/22/2004 | US20040014093 Polynucleotide encoding a novel cysteine protease of the calpain superfamily, Protease-42 |
| 01/22/2004 | US20040014092 Production of transgenic plants which synthesize long-chain inulin due to the introduction of nucleic acid molecules encoding a fructosyl transferase |
| 01/22/2004 | US20040014089 Culturing a transformant in a medium, allowing the polypeptide having phospholipase a2 activity fo form and accumulating in the culture, recovering the polypeptide thus formed |
| 01/22/2004 | US20040014085 Design of unpaired forward and reverse primers having homology to 5' end of one template and to the 3' end of another template; genetic engineering |
| 01/22/2004 | US20040014072 Novel dna synthase |
| 01/22/2004 | US20040014058 Novel human proteins, polynucleotides encoding them and methods of using the same |
| 01/22/2004 | US20040014039 Nucleic acids, proteins, and antibodies |
| 01/22/2004 | US20040014026 Methods for identifying compounds that inhibit ubiquitin-mediated proteolysis of IkappaB |
| 01/22/2004 | US20040014025 Using a transfer system which is contacted with the cell to be changed, the transfer system comprises a fusion protein which is transferred into the cell using the VirB/VirD4 transfer system |
| 01/22/2004 | US20040013739 Membrane fractions of 1,2-sn-diacylglycerol-enriched cells |
| 01/22/2004 | US20040013738 Encapsulation of liquid template particles |
| 01/22/2004 | US20040013658 Method of inducing apoptosis by reducing the level of thiamin |
| 01/22/2004 | US20040013657 Novel nucleic acids and polypeptides |
| 01/22/2004 | US20040013648 Vector system |
| 01/22/2004 | US20040013645 Methods and compounds for controlled release of recombinant parvovirus vectors |
| 01/22/2004 | CA2621517A1 Production of polyketides fkbp-ligand analogues |
| 01/22/2004 | CA2492711A1 Herbicide-resistant plants, and polynucleotides and methods for providing same |
| 01/22/2004 | CA2492691A1 Streptococcus pneumoniae pbp2x mini-protein and uses thereof |
| 01/22/2004 | CA2492642A1 Process for producing a decaffeinated coffee plant by genetic recombination |
| 01/22/2004 | CA2492203A1 Synthetic tag genes |
| 01/22/2004 | CA2491718A1 Process for producing a virus-inactivated thrombin preparation |
| 01/22/2004 | CA2491234A1 Use of a gene for increasing the oil content in plants |
| 01/22/2004 | CA2491080A1 Use of aspartic proteases in cosmetics and therapeutics |
| 01/22/2004 | CA2490666A1 Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase |
| 01/22/2004 | CA2433479A1 Conjugate of a tissue non-specific alkaline phosphatase and dextran, process for its production and use thereof |
| 01/21/2004 | EP1382691A2 Method for the isolation of the 20S proteasome, and methods for the identification of 20S and 26S proteasome inhibitors |
| 01/21/2004 | EP1382680A1 1,3-galactose transferase and dna encoding the enzyme |
| 01/21/2004 | EP1382674A2 Alpha-keto acid reductase, method for producing the same, and method for producing optically active alpha-hydroxy acids using the same |
| 01/21/2004 | EP1381686A2 Inactivation of genes of the mep pathway |
| 01/21/2004 | EP1381685A2 Genes and proteins for the biosynthesis of polyketides |
| 01/21/2004 | EP1381684A2 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 01/21/2004 | EP1381678A2 Nucleic acid modification enzymes |
| 01/21/2004 | EP1381676A2 Nucleic acid molecules encoding starch degrading enzymes |
| 01/21/2004 | EP1381672A1 Biosynthesis of polyketide synthase substrates |
| 01/21/2004 | EP1381631A2 Human timp-1 antibodies |
| 01/21/2004 | EP1381623A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/21/2004 | EP1381386A2 Novel mixtures of microbial enzymes |
| 01/21/2004 | EP1381349A1 Tyrosinase assay |